Intramuscular progesterone in women with twins and a prior singleton spontaneous preterm birth
Autor: | Vincenzo Berghella, Huda B. Al-Kouatly, Andrew Ward, Victoria Greenberg, Rupsa C. Boelig, Breanna Valcarcel |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Fetus Pregnancy Obstetrics business.industry Infant Newborn Retrospective cohort study General Medicine Odds ratio medicine.disease Article Intraventricular hemorrhage Intensive care Cohort 17 alpha-Hydroxyprogesterone Caproate medicine Humans Premature Birth Female Prospective Studies business Twin Pregnancy Progesterone Retrospective Studies |
Zdroj: | Am J Obstet Gynecol MFM |
ISSN: | 2589-9333 |
Popis: | BACKGROUND: Although the use of 17-alpha-hydroxyprogesterone caproate is one of the most commonly used strategies to reduce the risk of preterm birth since its approval by the Food and Drug Administration in 2011, there has been controversy recently that there may be no benefit associated with its use in singleton pregnancies in women with a prior history of spontaneous preterm birth. However, very few of these investigations evaluated the use of intramuscular progesterone in twin pregnancies. A few studies that used 17-alpha-hydroxyprogesterone caproate in twin pregnancies had mainly included unselected twin pregnancies. Although a twin pregnancy is independently associated with an increased likelihood of preterm birth, the primary indication for the use of supplemental progesterone in pregnancy is prior history of spontaneous preterm birth. Therefore, our investigation of weekly intramuscular progesterone in twin pregnancies with this birth history best addresses this question using a selected cohort. OBJECTIVE: To assess whether weekly 17-alpha-hydroxyprogesterone caproate prevents recurrent preterm birth in women with a current twin pregnancy and a prior singleton spontaneous preterm birth. STUDY DESIGN: This was a retrospective cohort study of women with twin pregnancy and a prior singleton spontaneous preterm birth in 2 institutions between January 2005 and December 2016. One group (intervention group) consisted of women who received weekly 17-alpha-hydroxyprogesterone caproate, whereas the other (control group) did not. The primary outcome was twin spontaneous preterm birth |
Databáze: | OpenAIRE |
Externí odkaz: |